FMDRX
Price
$32.55
Change
-$0.05 (-0.15%)
Updated
Jun 2 closing price
Net Assets
9.15B
TEBIX
Price
$18.38
Change
+$0.02 (+0.11%)
Updated
Jun 2 closing price
Net Assets
3.41B
Interact to see
Advertisement

FMDRX vs TEBIX

Header iconFMDRX vs TEBIX Comparison
Open Charts FMDRX vs TEBIXBanner chart's image
FMDRX vs TEBIX Comparison Chart in %
View a ticker or compare two or three
VS
FMDRX vs. TEBIX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FMDRX is a Buy and TEBIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FMDRX has more cash in the bank: 9.15B vs. TEBIX (3.41B). FMDRX pays higher dividends than TEBIX: FMDRX (1.82) vs TEBIX (1.15). FMDRX was incepted earlier than TEBIX: FMDRX (13 years) vs TEBIX (64 years). TEBIX (1.01) is less costly to investors than FMDRX (0.89). TEBIX is a more actively managed with annual turnover of: 46.86 vs. FMDRX (42.28). TEBIX has a lower initial minimum investment than FMDRX: TEBIX (1000) vs FMDRX (1000000). TEBIX annual gain was more profitable for investors over the last year : 8.50 vs. FMDRX (4.83). FMDRX return over 5 years is better than : 3.79 vs. TEBIX (2.95).
FMDRXTEBIXFMDRX / TEBIX
Total Expense Ratio0.891.0188%
Annual Report Gross Expense Ratio0.891.0188%
Fund Existence13 years64 years-
Gain YTD1.6840.273617%
Front LoadN/A6%-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets9.15B3.41B269%
Annual Yield % from dividends1.821.15159%
Returns for 1 year4.838.5057%
Returns for 3 years18.1930.4360%
Returns for 5 years3.792.95128%
Returns for 10 years21.6534.2763%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UMBF129.211.06
+0.83%
UMB Financial Corp
CCRN13.09N/A
N/A
Cross Country Healthcare
SGA9.37-0.06
-0.64%
Saga Communications
LANDO20.65-0.21
-1.01%
Gladstone Land Corp
RXRX3.62-0.18
-4.62%
Recursion Pharmaceuticals